Trade QNCX anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Quince Therapeutics, Inc. (QNCX) is trading at US$34.23, up 5.31% today as of Aug 28, 12:59 EDT. The company has a market capitalisation of US$34.51M. Over the past 52 weeks, QNCX has traded between US$15.10 and US$909.98. On Syfe you can trade QNCX with $0 commission and add it to your watchlist.
| Previous close | US$32.50 |
|---|---|
| Market cap | US$34.51M |
| 52-week range | US$15.10 – US$909.98 |
| Volume | 16.52K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Quince Therapeutics, Inc.
Quince Therapeutics, Inc. is a biopharmaceutical company, which engages in unlocking the power of a patient’s biology for the treatment of rare diseases. Its product includes eDSP, developed using their proprietary Autologous Intracellular Drug Encapsulation (AIDE) technology platform, which is a novel device combination that uses an automated process designed to encapsulate a drug into the patient’s own red blood cells. The company was founded by Casey Crawford Lynch, Stephen Dominy and Kristen Gafric on June 20, 2012 and is headquartered in South San Francisco, CA.
Year: 2019
--Oppenheimer Initiates Quince Therapeutics at Outperform With $82 Price Target
Jul 29, 12:54 PM · MT Newswires
--Leerink Partners Initiates Quince Therapeutics at Outperform With $4 Price Target
Jun 24, 11:37 AM · MT Newswires
--Cantor Fitzgerald Initiates Quince Therapeutics at Overweight With $4 Price Target
Jun 23, 11:05 AM · MT Newswires
Quince Therapeutics, Inc. (QNCX) stock is trading at US$34.23, +5.31% from the previous close of US$32.50.
The market cap for Quince Therapeutics, Inc. (QNCX) stock is approximately US$34.51M.
The 52-week high for Quince Therapeutics, Inc. (QNCX) stock is US$909.98.
The 52-week low for Quince Therapeutics, Inc. (QNCX) stock is US$15.10.
Quince Therapeutics, Inc. (QNCX) does not currently pay a dividend.
Stay on top of QNCX
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
